Aneuclose

Aneuclose is a private U.S. medical device company developing endovascular devices for the treatment of cerebral aneurysms. The company appears focused on intrasaccular aneurysm occlusion systems designed to bridge the aneurysm neck and promote embolization within the aneurysm sac. Publicly visible information indicates an IP-driven development strategy centered on multiple patented and patent-pending device designs rather than an approved commercial product portfolio. Its programs include concepts such as the Janjua Aneurysm Net and related neck-bridge and mesh-based occlusion devices intended for neurovascular intervention. Based on the available evidence, Aneuclose is an early-stage device developer rather than a therapeutics company.